- (-%)
Source:
Vicapsys is focused on leveraging natural pathways in a localized manner in order to achieve beneficial therapies without systemic negative consequences. At the core of Vicapsys technology is a pleiotropic cytokine, CXCL12 that can be optimally formulated to achieve therapeutic outcomes in different indications.
Country | United States |
Headquarters | cumming, georgia |
Phone Number | 470-514-4013 |
Industry | manufacturing |
CEO | Federico Pier |
Website | vicapsys.com |